We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Cannabis investors saw a pair of notable moves in popular stocks on Monday, with Canopy Growth (CGC - Free Report) moving 11% and Aurora Cannabis (ACB - Free Report) adding nearly 7% on the back of exciting deals for both companies.
Canopy Growth on Monday received a license from New York that will allow the Canadian company to process and produce hemp in the state. The move is a part of larger efforts from New York Governor Andrew Cuomo and U.S. Senator Charles Schumer as well as Canopy’s own hopes to break into the U.S. market.
In a company press release, Canopy cited Cuomo’s help in creating the Hemp Research Pilot Program and Schumer’s leadership in passing the recent U.S. farm bill as being instrumental in getting the deal done. The 2018 edition of the farm bill legalized the production of hemp in the United States.
A final location for Canopy Growth’s New York site will depend on a board vote, but the company is currently evaluating a number of spots in the Southern Tier of the state, according to CNBC. Canopy plans to invest up to $150 million in the location, which it hopes will be “capable of producing tons of hemp” annually.
Schumer’s office added in its own release that the company’s investment “is a true win-win for Canopy Growth, who will be positioned at the forefront of Upstate New York's industrial hemp revolution, and for the Southern Tier's economy and farmers, which will receive a major shot in the arm in new good-paying jobs.”
Meanwhile, fellow Canadian marijuana producer Aurora Cannabis announced Monday that it is acquiring British Columbia-based Whistler Medical Marijuana for about $132 million. Whistler is a recognizable brand in Canada and received one of the country’s original 10 licenses to produce marijuana. It was also the first marijuana company to earn organic certification in Canada.
“This transaction adds an iconic, organic certified BC-based brand with exceptional traction and a significant price premium in both the medical and retail markets,” said Aurora CEO Terry Booth.
On top of its recognizability, Whistler offers Aurora a unique opportunity to expand internationally, as it already sells medical cannabis derivatives to Australia and the Cayman Islands. Whistler’s second production facility is expected to be completed this summer and will have a capacity of over 5,000 kilograms per year.
Canopy Growth and Aurora’s deal-making spread optimism to the rest of the marijuana industry during the week’s first trading session. The ETFMG Alternative Harvest ETF (MJ - Free Report) gained 1.7% on Monday, underscoring hopes for more major deals that can add legitimacy to the young business.
Today's Stocks from Zacks' Hottest Strategies
It's hard to believe, even for us at Zacks. But while the market gained +21.9% in 2017, our top stock-picking screens have returned +115.0%, +109.3%, +104.9%, +98.6%, and +67.1%.
And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - 2017, the composite yearly average gain for these strategies has beaten the market more than 19X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.
Image: Bigstock
Cannabis Investing News: Why CHC & ACB Stock Climbed Today
Cannabis investors saw a pair of notable moves in popular stocks on Monday, with Canopy Growth (CGC - Free Report) moving 11% and Aurora Cannabis (ACB - Free Report) adding nearly 7% on the back of exciting deals for both companies.
Canopy Growth on Monday received a license from New York that will allow the Canadian company to process and produce hemp in the state. The move is a part of larger efforts from New York Governor Andrew Cuomo and U.S. Senator Charles Schumer as well as Canopy’s own hopes to break into the U.S. market.
In a company press release, Canopy cited Cuomo’s help in creating the Hemp Research Pilot Program and Schumer’s leadership in passing the recent U.S. farm bill as being instrumental in getting the deal done. The 2018 edition of the farm bill legalized the production of hemp in the United States.
A final location for Canopy Growth’s New York site will depend on a board vote, but the company is currently evaluating a number of spots in the Southern Tier of the state, according to CNBC. Canopy plans to invest up to $150 million in the location, which it hopes will be “capable of producing tons of hemp” annually.
Schumer’s office added in its own release that the company’s investment “is a true win-win for Canopy Growth, who will be positioned at the forefront of Upstate New York's industrial hemp revolution, and for the Southern Tier's economy and farmers, which will receive a major shot in the arm in new good-paying jobs.”
Meanwhile, fellow Canadian marijuana producer Aurora Cannabis announced Monday that it is acquiring British Columbia-based Whistler Medical Marijuana for about $132 million. Whistler is a recognizable brand in Canada and received one of the country’s original 10 licenses to produce marijuana. It was also the first marijuana company to earn organic certification in Canada.
“This transaction adds an iconic, organic certified BC-based brand with exceptional traction and a significant price premium in both the medical and retail markets,” said Aurora CEO Terry Booth.
On top of its recognizability, Whistler offers Aurora a unique opportunity to expand internationally, as it already sells medical cannabis derivatives to Australia and the Cayman Islands. Whistler’s second production facility is expected to be completed this summer and will have a capacity of over 5,000 kilograms per year.
Canopy Growth and Aurora’s deal-making spread optimism to the rest of the marijuana industry during the week’s first trading session. The ETFMG Alternative Harvest ETF (MJ - Free Report) gained 1.7% on Monday, underscoring hopes for more major deals that can add legitimacy to the young business.
Today's Stocks from Zacks' Hottest Strategies
It's hard to believe, even for us at Zacks. But while the market gained +21.9% in 2017, our top stock-picking screens have returned +115.0%, +109.3%, +104.9%, +98.6%, and +67.1%.
And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - 2017, the composite yearly average gain for these strategies has beaten the market more than 19X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.
See Them Free>>